1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:735316 6480464 o, p'-DDT results in increased expression of SLC38A1 mRNA CTD PMID:18204070 1,2-dichloroethane increases expression ISO RGD:731314 6480464 ethylene dichloride results in increased expression of SLC38A1 mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:731314 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of SLC38A1 mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:731314 6480464 1, 2-Dimethylhydrazine results in increased expression of SLC38A1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of SLC38A1 mRNA CTD PMID:29097150 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:735316 6480464 Dihydrotestosterone results in increased expression of SLC38A1 mRNA CTD PMID:29581250 2,3',4,4',5-Pentachlorobiphenyl decreases expression ISO RGD:731314 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731314 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC38A1 mRNA CTD PMID:19770486 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:735316 6480464 2 more ... CTD PMID:26705709 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:731314 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of SLC38A1 mRNA CTD PMID:26251327 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:735316 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SLC38A1 mRNA CTD PMID:28628672 acetamide increases expression EXP 6480464 acetamide results in increased expression of SLC38A1 mRNA CTD PMID:31881176 acrylamide increases expression ISO RGD:735316 6480464 Acrylamide results in increased expression of SLC38A1 mRNA CTD PMID:32763439 all-trans-retinoic acid decreases expression ISO RGD:735316 6480464 Tretinoin results in decreased expression of SLC38A1 mRNA CTD PMID:23724009 , PMID:33167477 all-trans-retinoic acid increases expression ISO RGD:735316 6480464 Tretinoin results in increased expression of SLC38A1 protein CTD PMID:30093655 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of SLC38A1 mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO RGD:735316 6480464 Antirheumatic Agents results in decreased expression of SLC38A1 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:735316 6480464 aristolochic acid I results in decreased expression of SLC38A1 mRNA CTD PMID:33212167 arsenous acid increases expression ISO RGD:735316 6480464 Arsenic Trioxide results in increased expression of SLC38A1 protein CTD PMID:30093655 atrazine decreases expression ISO RGD:735316 6480464 Atrazine results in decreased expression of SLC38A1 mRNA CTD PMID:22378314 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of SLC38A1 gene CTD PMID:35440735 benzo[a]pyrene decreases expression ISO RGD:735316 6480464 Benzo(a)pyrene results in decreased expression of SLC38A1 mRNA CTD PMID:20064835 benzo[a]pyrene decreases methylation ISO RGD:735316 6480464 Benzo(a)pyrene results in decreased methylation of SLC38A1 5' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:735316 6480464 Benzo(a)pyrene affects the methylation of SLC38A1 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:735316 6480464 Benzo(a)pyrene results in increased expression of SLC38A1 mRNA CTD PMID:26238291 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:735316 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 benzo[a]pyrene diol epoxide I increases expression ISO RGD:735316 6480464 7 more ... CTD PMID:26238291 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC38A1 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:735316 6480464 bisphenol A results in increased expression of SLC38A1 mRNA CTD PMID:29275510 bisphenol A affects expression ISO RGD:735316 6480464 bisphenol A affects the expression of SLC38A1 mRNA CTD PMID:30903817 bisphenol A multiple interactions ISO RGD:735316 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SLC38A1 mRNA CTD PMID:28628672 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC38A1 mRNA CTD PMID:29097150 bisphenol A decreases expression ISO RGD:731314 6480464 bisphenol A results in decreased expression of SLC38A1 mRNA CTD PMID:25594700 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of SLC38A1 mRNA CTD PMID:33453195 cadmium sulfate increases expression ISO RGD:735316 6480464 cadmium sulfate results in increased expression of SLC38A1 mRNA CTD PMID:12064557 , PMID:14676411 calyculin a increases expression ISO RGD:731314 6480464 calyculin A results in increased expression of SLC38A1 mRNA CTD PMID:25270620 cannabidiol decreases expression ISO RGD:731314 6480464 Cannabidiol results in decreased expression of SLC38A1 mRNA CTD PMID:33019509 cannabigerol decreases expression ISO RGD:731314 6480464 cannabigerol results in decreased expression of SLC38A1 mRNA CTD PMID:33019509 carbon nanotube decreases expression ISO RGD:731314 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:735316 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC38A1 gene] CTD PMID:28238834 chloropicrin increases expression ISO RGD:735316 6480464 chloropicrin results in increased expression of SLC38A1 mRNA CTD PMID:26352163 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of SLC38A1 mRNA CTD PMID:18668222 chlorpyrifos decreases expression ISO RGD:731314 6480464 Chlorpyrifos results in decreased expression of SLC38A1 mRNA CTD PMID:37019170 choline multiple interactions ISO RGD:731314 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC38A1 mRNA CTD PMID:20938992 cisplatin increases expression ISO RGD:735316 6480464 Cisplatin results in increased expression of SLC38A1 mRNA CTD PMID:27594783 cobalt dichloride decreases expression ISO RGD:735316 6480464 cobaltous chloride results in decreased expression of SLC38A1 mRNA CTD PMID:19320972 copper atom multiple interactions ISO RGD:731314 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SLC38A1 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:731314 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SLC38A1 mRNA CTD PMID:15467011 copper(II) sulfate increases expression ISO RGD:735316 6480464 Copper Sulfate results in increased expression of SLC38A1 mRNA CTD PMID:19549813 crocidolite asbestos affects expression ISO RGD:735316 6480464 Asbestos, Crocidolite affects the expression of SLC38A1 mRNA CTD PMID:25757056 cyclosporin A increases expression ISO RGD:735316 6480464 Cyclosporine results in increased expression of SLC38A1 mRNA CTD PMID:20106945 more ... deguelin increases expression ISO RGD:735316 6480464 deguelin results in increased expression of SLC38A1 mRNA CTD PMID:33512557 dexamethasone multiple interactions ISO RGD:735316 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SLC38A1 mRNA CTD PMID:28628672 dextran sulfate decreases expression ISO RGD:731314 6480464 Dextran Sulfate results in decreased expression of SLC38A1 mRNA CTD PMID:35093514 diarsenic trioxide increases expression ISO RGD:735316 6480464 Arsenic Trioxide results in increased expression of SLC38A1 protein CTD PMID:30093655 diazinon increases methylation ISO RGD:735316 6480464 Diazinon results in increased methylation of SLC38A1 gene CTD PMID:22964155 dieldrin increases expression EXP 6480464 Dieldrin results in increased expression of SLC38A1 mRNA CTD PMID:23153324 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SLC38A1 mRNA CTD PMID:29391264 ethanol affects splicing ISO RGD:731314 6480464 Ethanol affects the splicing of SLC38A1 mRNA CTD PMID:30319688 fenpyroximate increases expression ISO RGD:735316 6480464 fenpyroximate results in increased expression of SLC38A1 mRNA CTD PMID:33512557 fenvalerate decreases expression ISO RGD:731314 6480464 fenvalerate results in decreased expression of SLC38A1 mRNA CTD PMID:28369636 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of SLC38A1 mRNA CTD PMID:30307764 folic acid multiple interactions ISO RGD:731314 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC38A1 mRNA more ... CTD PMID:20938992 , PMID:22206623 formaldehyde increases expression ISO RGD:731314 6480464 Formaldehyde results in increased expression of SLC38A1 mRNA CTD PMID:33259821 fulvestrant increases methylation ISO RGD:735316 6480464 Fulvestrant results in increased methylation of SLC38A1 gene CTD PMID:31601247 gamma-aminobutyric acid decreases expression EXP 6480464 gamma-Aminobutyric Acid results in decreased expression of SLC38A1 mRNA CTD PMID:26924987 geldanamycin increases expression ISO RGD:735316 6480464 geldanamycin results in increased expression of SLC38A1 mRNA CTD PMID:26705709 graphite affects expression EXP 6480464 Graphite affects the expression of SLC38A1 mRNA CTD PMID:29933104 heptachlor increases expression EXP 6480464 Heptachlor results in increased expression of SLC38A1 mRNA CTD PMID:23153324 hydrogen chloride multiple interactions ISO RGD:731314 6480464 [NFE2L2 gene mutant form results in increased susceptibility to Hydrochloric Acid] which results in increased expression of SLC38A1 mRNA CTD PMID:29618784 indometacin multiple interactions ISO RGD:735316 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SLC38A1 mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:735316 6480464 Ivermectin results in decreased expression of SLC38A1 protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:731314 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC38A1 mRNA CTD PMID:20938992 lipopolysaccharide multiple interactions ISO RGD:735316 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SLC38A1 mRNA CTD PMID:35811015 manganese atom decreases expression EXP 6480464 Manganese results in decreased expression of SLC38A1 mRNA CTD PMID:17468184 manganese(0) decreases expression EXP 6480464 Manganese results in decreased expression of SLC38A1 mRNA CTD PMID:17468184 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of SLC38A1 gene CTD PMID:35440735 methyl methanesulfonate decreases expression ISO RGD:735316 6480464 Methyl Methanesulfonate results in decreased expression of SLC38A1 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:735316 6480464 methylmercuric chloride results in increased expression of SLC38A1 mRNA CTD PMID:26272509 mirex increases expression EXP 6480464 Mirex results in increased expression of SLC38A1 mRNA CTD PMID:23153324 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of SLC38A1 gene, [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of SLC38A1 mRNA CTD PMID:28659758 , PMID:33148267 nickel dichloride increases expression ISO RGD:735316 6480464 nickel chloride results in increased expression of SLC38A1 mRNA CTD PMID:17312168 oxaliplatin decreases expression ISO RGD:735316 6480464 oxaliplatin results in decreased expression of SLC38A1 mRNA CTD PMID:16510598 paracetamol affects expression ISO RGD:731314 6480464 Acetaminophen affects the expression of SLC38A1 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SLC38A1 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:735316 6480464 Acetaminophen results in increased expression of SLC38A1 mRNA CTD PMID:29067470 paracetamol decreases expression ISO RGD:735316 6480464 Acetaminophen results in decreased expression of SLC38A1 mRNA CTD PMID:21420995 perfluorononanoic acid increases expression ISO RGD:735316 6480464 perfluoro-n-nonanoic acid results in increased expression of SLC38A1 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:735316 6480464 perfluorooctane sulfonic acid results in decreased expression of SLC38A1 mRNA CTD PMID:32790152 perfluorooctanoic acid decreases expression ISO RGD:735316 6480464 perfluorooctanoic acid results in decreased expression of SLC38A1 mRNA CTD PMID:32790152 perfluorooctanoic acid multiple interactions ISO RGD:735316 6480464 [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of SLC38A1 mRNA CTD PMID:33325755 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of SLC38A1 gene, [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of SLC38A1 mRNA CTD PMID:28659758 , PMID:33148267 phytoestrogen multiple interactions ISO RGD:735316 6480464 [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of SLC38A1 mRNA CTD PMID:33325755 pirinixic acid increases expression ISO RGD:731314 6480464 pirinixic acid results in increased expression of SLC38A1 mRNA CTD PMID:20813756 progesterone increases expression EXP 6480464 Progesterone results in increased expression of SLC38A1 mRNA CTD PMID:20726854 Pyridostigmine bromide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of SLC38A1 mRNA CTD PMID:28659758 quercetin increases expression ISO RGD:735316 6480464 Quercetin results in increased expression of SLC38A1 mRNA CTD PMID:21632981 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:735316 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SLC38A1 mRNA CTD PMID:35811015 silicon dioxide increases expression ISO RGD:735316 6480464 Silicon Dioxide analog results in increased expression of SLC38A1 mRNA CTD PMID:25895662 sodium arsenate decreases expression ISO RGD:731314 6480464 sodium arsenate results in decreased expression of SLC38A1 mRNA CTD PMID:21795629 sunitinib increases expression ISO RGD:735316 6480464 Sunitinib results in increased expression of SLC38A1 mRNA CTD PMID:31533062 T-2 toxin decreases expression ISO RGD:735316 6480464 T-2 Toxin results in decreased expression of SLC38A1 mRNA CTD PMID:31863870 temozolomide increases expression ISO RGD:735316 6480464 Temozolomide results in increased expression of SLC38A1 mRNA CTD PMID:31758290 thapsigargin increases expression ISO RGD:735316 6480464 Thapsigargin results in increased expression of SLC38A1 mRNA CTD PMID:22378314 thifluzamide increases expression ISO RGD:735316 6480464 thifluzamide results in increased expression of SLC38A1 mRNA CTD PMID:33512557 thimerosal decreases expression ISO RGD:735316 6480464 Thimerosal results in decreased expression of SLC38A1 mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SLC38A1 mRNA CTD PMID:34492290 trichostatin A affects expression ISO RGD:735316 6480464 trichostatin A affects the expression of SLC38A1 mRNA CTD PMID:28542535 trimellitic anhydride increases expression ISO RGD:731314 6480464 trimellitic anhydride results in increased expression of SLC38A1 mRNA CTD PMID:19042947 triptonide decreases expression ISO RGD:731314 6480464 triptonide results in decreased expression of SLC38A1 mRNA CTD PMID:33045310 tunicamycin increases expression ISO RGD:735316 6480464 Tunicamycin results in increased expression of SLC38A1 mRNA CTD PMID:29453283 valproic acid decreases expression ISO RGD:731314 6480464 Valproic Acid results in decreased expression of SLC38A1 mRNA CTD PMID:21427059 valproic acid decreases expression ISO RGD:735316 6480464 Valproic Acid results in decreased expression of SLC38A1 mRNA CTD PMID:28001369 valproic acid affects expression ISO RGD:735316 6480464 Valproic Acid affects the expression of SLC38A1 mRNA CTD PMID:25979313 vorinostat decreases expression ISO RGD:735316 6480464 vorinostat results in decreased expression of SLC38A1 mRNA CTD PMID:27188386 zearalenone decreases expression EXP 6480464 Zearalenone results in decreased expression of SLC38A1 mRNA, Zearalenone results in decreased expression of SLC38A1 protein CTD PMID:32858132